{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:09:56Z","timestamp":1781723396579,"version":"3.54.5"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.intimp.2026.116444","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T08:54:03Z","timestamp":1772700843000},"page":"116444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["CuET inhibits Ewing sarcoma of bone progression through modulation of the ESM1-MAPK\/ERK signaling axis"],"prefix":"10.1016","volume":"175","author":[{"given":"Wantong","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongbiao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116444_bb0005","article-title":"Inhibition of SOX2 induces cell apoptosis and G1\/S arrest in Ewing\u2019s sarcoma through the PI3K\/Akt pathway","volume":"35","author":"C","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.intimp.2026.116444_bb0010","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1158\/0008-5472.CAN-20-1458","article-title":"Ubiquitin-specific protease 6 functions as a tumor suppressor in Ewing sarcoma through immune activation","volume":"81","author":"Henrich","year":"2021","journal-title":"Cancer Res."},{"issue":"15","key":"10.1016\/j.intimp.2026.116444_bb0015","first-page":"1477","article-title":"Ewing\u2019s sarcoma","volume":"384","author":"Blay","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.intimp.2026.116444_bb0020","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1200\/JCO.2005.05.105","article-title":"Survival after recurrence of Ewing\u2019s sarcoma family of tumors","volume":"23","author":"Barker","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116444_bb0025","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/cncr.10192","article-title":"Survival after recurrence of Ewing tumors: the St Jude Children\u2019s Research Hospital experience, 1979-1999","volume":"94","author":"Rodriguez-Galindo","year":"2002","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.intimp.2026.116444_bb0030","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1093\/annonc\/mdg457","article-title":"Therapy and survival after recurrence of Ewing\u2019s tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997","volume":"14","author":"Bacci","year":"2003","journal-title":"Ann. Oncol."},{"issue":"12","key":"10.1016\/j.intimp.2026.116444_bb0035","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/CM9.0000000000002909","article-title":"Disulfiram: a novel repurposed drug for cancer therapy","volume":"137","author":"Zeng","year":"2024","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.intimp.2026.116444_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-022-02661-4","article-title":"DSF\/cu induces antitumor effect against diffuse large B-cell lymphoma through suppressing NF-\u03baB\/BCL6 pathways","volume":"22","author":"Zhu","year":"2022","journal-title":"Cancer Cell Int."},{"issue":"7","key":"10.1016\/j.intimp.2026.116444_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41418-023-01167-4","article-title":"Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET","volume":"30","author":"Kanellis","year":"2023","journal-title":"Cell Death Differ."},{"issue":"10","key":"10.1016\/j.intimp.2026.116444_bb0050","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/bjc.2011.126","article-title":"Disulfiram modulated ROS-MAPK and NF\u03baB pathways and targeted breast cancer cells with cancer stem cell-like properties","volume":"104","author":"Yip","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.intimp.2026.116444_bb0055","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s41416-019-0609-0","article-title":"Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies","volume":"121","author":"Kita","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.116444_bb0060","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/jcmm.13334","article-title":"Disulfiram combined with copper inhibits metastasis and epithelial\u2013mesenchymal transition in hepatocellular carcinoma through the NF-\u03baB and TGF-\u03b2 pathways","volume":"22","author":"Li","year":"2018","journal-title":"J. Cell. Mol. Med."},{"issue":"10","key":"10.1016\/j.intimp.2026.116444_bb0065","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1039\/C7SC04853J","volume":"9","author":"Zhao","year":"2018","journal-title":"Chem. Sci."},{"issue":"21","key":"10.1016\/j.intimp.2026.116444_bb0070","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1158\/0008-5472.CAN-06-2126","article-title":"Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity","volume":"66","author":"Chen","year":"2006","journal-title":"Cancer Res."},{"issue":"27","key":"10.1016\/j.intimp.2026.116444_bb0075","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1021\/jm049568z","article-title":"Disulfiram facilitates intracellular cu uptake and induces apoptosis in human melanoma cells","volume":"47","author":"Cen","year":"2004","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.intimp.2026.116444_bb0080","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/stem.1956","article-title":"Concise review: bullseye: targeting cancer stem cells to improve the treatment of gliomas by repurposing disulfiram","volume":"33","author":"Triscott","year":"2015","journal-title":"Stem Cells (Dayton, Ohio)"},{"key":"10.1016\/j.intimp.2026.116444_bb0085","article-title":"DDTC-Cu(I) inhibits human osteosarcoma cells growth by repressing MET\/PI3K\/AKT signaling pathway","volume":"15","author":"Zhou","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2026.116444_bb0090","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7150\/ijbs.66839","article-title":"Validation of ESM1 related to ovarian Cancer and the biological function and prognostic significance","volume":"19","author":"Li","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2026.116444_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-05501-5","article-title":"Endothelial cell-specific molecule 1 drives cervical cancer progression","volume":"13","author":"Lu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"15","key":"10.1016\/j.intimp.2026.116444_bb0100","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1158\/1078-0432.CCR-06-0185","article-title":"Endocan expression and relationship with survival in human non-small cell lung cancer","volume":"12","author":"Grigoriu","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"28","key":"10.1016\/j.intimp.2026.116444_bb0105","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.3748\/wjg.14.4562","article-title":"Correlation between expression and differentiation of endocan in colorectal cancer","volume":"14","author":"Zuo","year":"2008","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116444_bb0110","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2559.2009.03458.x","article-title":"Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma","volume":"56","author":"Leroy","year":"2010","journal-title":"Histopathology"},{"issue":"10","key":"10.1016\/j.intimp.2026.116444_bb0115","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1245\/s10434-010-1037-9","article-title":"Overexpression of endothelial cell specific molecule-1 (ESM-1) in gastric cancer","volume":"17","author":"Liu","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.intimp.2026.116444_bb0120","article-title":"B cell lymphoma 6 promotes hepatocellular carcinoma progression by inhibiting tumor infiltrating CD4+T cell cytotoxicity through ESM1","volume":"8","author":"Li","year":"2024","journal-title":"NPJ Precis. Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116444_bb0125","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1750-3639.2012.00578.x","article-title":"Endothelial expression of endocan is strongly associated with tumor progression in pituitary adenoma","volume":"22","author":"Cornelius","year":"2012","journal-title":"Brain Pathol. (Zurich, Switzerland)"},{"key":"10.1016\/j.intimp.2026.116444_bb0130","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-024-02009-8","article-title":"ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent Warburg effect within the hypoxic tumor microenvironment","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2026.116444_bb0135","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020105450","article-title":"Direct interaction of \u03b2-catenin with nuclear ESM1 supports stemness of metastatic prostate cancer","volume":"40","author":"Pan","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.intimp.2026.116444_bb0140","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.omtn.2019.09.023","article-title":"Exosomal MicroRNA-9-3p secreted from BMSCs downregulates ESM1 to suppress the development of bladder cancer","volume":"18","author":"Cai","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"7","key":"10.1016\/j.intimp.2026.116444_bb0145","doi-asserted-by":"crossref","DOI":"10.21037\/atm-20-7005","article-title":"ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT\/NF-\u03baB\/cyclin D1 pathway","volume":"9","author":"Liu","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.intimp.2026.116444_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.771579","article-title":"EMS1\/DLL4-notch signaling axis augments cell cycle-mediated tumorigenesis and progress in human adrenocortical carcinoma","volume":"11","author":"Huang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2026.116444_bb0155","doi-asserted-by":"crossref","unstructured":"Kumar S K, Mani K P. Endocan alters nitric oxide production in endothelial cells by targeting AKT\/eNOS and NFkB\/iNOS signaling. Nitric Oxide Biol. Chem., 2021, 117: 26\u201333. DOI:https:\/\/doi.org\/10.1016\/j.niox.2021.09.006.","DOI":"10.1016\/j.niox.2021.09.006"},{"issue":"5","key":"10.1016\/j.intimp.2026.116444_bb0160","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s40265-018-0884-8","article-title":"BRAF and MEK inhibitors: use and resistance in BRAF-mutated cancers","volume":"78","author":"Sanchez","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.intimp.2026.116444_bb0165","doi-asserted-by":"crossref","unstructured":"Zhang J, Yang T, Han M, et al. Gain-of-function mutations in the catalytic domain of DOT1L promote lung cancer malignant phenotypes via the MAPK\/ERK signaling pathway. Sci. Adv., 9(22): eadc9273. DOI:https:\/\/doi.org\/10.1126\/sciadv.adc9273.","DOI":"10.1126\/sciadv.adc9273"},{"issue":"2","key":"10.1016\/j.intimp.2026.116444_bb0170","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ccell.2018.06.012","article-title":"MAST1 drives cisplatin resistance in human cancers by rewiring cRaf independent MEK activation","volume":"34","author":"Jin","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.116444_bb0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.semcancer.2019.11.011","article-title":"Oncogenic signaling pathways associated with immune evasion and resistance to immune checkpoint inhibitors in cancer","volume":"65","author":"Kobayashi","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.intimp.2026.116444_bb0180","doi-asserted-by":"crossref","unstructured":"Vasileva E, Warren M, Triche T J, et al. Dysregulated heparan sulfate proteoglycan metabolism promotes Ewing sarcoma tumor growth. eLife, 11: e69734. DOI:https:\/\/doi.org\/10.7554\/eLife.69734.","DOI":"10.7554\/eLife.69734"},{"key":"10.1016\/j.intimp.2026.116444_bb0185","article-title":"PKMYT1 kinase ameliorates cisplatin sensitivity in osteosarcoma","volume":"10","author":"Liu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.116444_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.dci.2021.104160","article-title":"Expression and functional analysis of the BCL2-associated agonist of cell death (BAD) gene in grass carp (Ctenopharyngodon idella) during bacterial infection","volume":"123","author":"Lu","year":"2021","journal-title":"Dev. Comp. Immunol."},{"key":"10.1016\/j.intimp.2026.116444_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.aquatox.2023.106698","article-title":"Climbazole causes cell apoptosis and lipidosis in the liver of grass carp","volume":"263","author":"Lu","year":"2023","journal-title":"Aquat. Toxicol."},{"issue":"36","key":"10.1016\/j.intimp.2026.116444_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202302368","article-title":"Targeting CBX3 with a dual BET\/PLK1 inhibitor enhances the antitumor efficacy of CDK4\/6 inhibitors in prostate cancer","volume":"10","author":"Liang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.intimp.2026.116444_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2024.133463","article-title":"An azole fungicide climbazole damages the gut-brain axis in the grass carp","volume":"465","author":"Lu","year":"2024","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.intimp.2026.116444_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.171475","article-title":"The azole biocide climbazole induces oxidative stress, inflammation, and apoptosis in fish gut","volume":"923","author":"Lu","year":"2024","journal-title":"Sci. Total Environ."},{"issue":"5","key":"10.1016\/j.intimp.2026.116444_bb0215","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1021\/acs.est.4c12695","article-title":"Benzimidazole fungicide carbendazim induces gut inflammation through the TLR5\/NF-\u03baB pathway in grass carp","volume":"59","author":"Lu","year":"2025","journal-title":"Environ. Sci. Technol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116444_bb0220","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-018-0003-x","article-title":"Ewing sarcoma","volume":"4","author":"Gr\u00fcnewald","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"15","key":"10.1016\/j.intimp.2026.116444_bb0225","article-title":"Ewing\u2019s sarcoma","volume":"384","author":"Ludwig","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.intimp.2026.116444_bb0230","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1470-2045(09)70286-4","article-title":"Ewing\u2019s sarcoma","volume":"11","author":"Balamuth","year":"2010","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116444_bb0235","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009726","article-title":"Circumventing resistance within the Ewing sarcoma microenvironment by combinatorial innate immunotherapy","volume":"12","author":"Luo","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.116444_bb0240","doi-asserted-by":"crossref","DOI":"10.1038\/s41389-020-00295-7","article-title":"Diethyldithiocarbamate-copper complex (CuET) inhibits colorectal cancer progression via miR-16-5p and 15b-5p\/ALDH1A3\/PKM2 axis-mediated aerobic glycolysis pathway","volume":"10","author":"Huang","year":"2021","journal-title":"Oncogenesis"},{"key":"10.1016\/j.intimp.2026.116444_bb0245","first-page":"96","article-title":"Combination of disulfiram and copper\u2212Cysteamine nanoparticles induces mitochondria damage and promotes apoptosis in endometrial cancer","volume":"36","author":"Yang","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.intimp.2026.116444_bb0250","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.biocel.2017.01.007","article-title":"The selective cytotoxicity of DSF-cu attributes to the biomechanical properties and cytoskeleton rearrangements in the normal and cancerous nasopharyngeal epithelial cells","volume":"84","author":"Yang","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.intimp.2026.116444_bb0255","first-page":"1","article-title":"Suppressing autophagy enhances disulfiram\/copper-induced apoptosis in non-small cell lung cancer","volume":"827","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"38","key":"10.1016\/j.intimp.2026.116444_bb0260","doi-asserted-by":"crossref","first-page":"40907","DOI":"10.18632\/oncotarget.5723","article-title":"Disulfiram inhibits TGF-\u03b2-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK\/NF-\u03baB\/snail pathway","volume":"6","author":"Han","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2026.116444_bb0265","article-title":"Targeting endothelial cell-specific molecule 1 protein in cancer: a promising therapeutic approach","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2026.116444_bb0270","doi-asserted-by":"crossref","unstructured":"D B, T G, M D, et al. Endocan is a novel chondroitin sulfate\/dermatan sulfate proteoglycan that promotes hepatocyte growth factor\/scatter factor mitogenic activity. J. Biol. Chem., 2001, 276(51) [2025-04-27]. https:\/\/pubmed.ncbi.nlm.nih.gov\/11590178\/. DOI:https:\/\/doi.org\/10.1074\/jbc.M108395200.","DOI":"10.1074\/jbc.M108395200"},{"issue":"5","key":"10.1016\/j.intimp.2026.116444_bb0275","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1159\/000025758","article-title":"Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies","volume":"37","author":"Bechard","year":"2000","journal-title":"J. Vasc. Res."},{"issue":"3","key":"10.1016\/j.intimp.2026.116444_bb0280","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.mvr.2006.05.010","article-title":"Vascular endocan is preferentially expressed in tumor endothelium","volume":"72","author":"Abid","year":"2006","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.intimp.2026.116444_bb0285","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-019-0833-y","article-title":"Identification of ESM1 overexpressed in head and neck squamous cell carcinoma","volume":"19","author":"Xu","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"3","key":"10.1016\/j.intimp.2026.116444_bb0290","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1158\/0008-5472.CAN-12-1855","article-title":"Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis","volume":"73","author":"Roudnicky","year":"2013","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.intimp.2026.116444_bb0295","doi-asserted-by":"crossref","first-page":"13886","DOI":"10.18632\/oncotarget.14684","article-title":"Loss of endothelial cell-specific molecule 1 promotes the tumorigenicity and metastasis of prostate cancer cells through regulation of the TIMP-1\/MMP-9 expression","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.intimp.2026.116444_bb0300","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.cellsig.2012.06.004","article-title":"ESM-1 regulates cell growth and metastatic process through activation of NF-\u03baB in colorectal cancer","volume":"24","author":"Kang","year":"2012","journal-title":"Cell. Signal."},{"issue":"12","key":"10.1016\/j.intimp.2026.116444_bb0305","doi-asserted-by":"crossref","first-page":"14429","DOI":"10.18632\/oncotarget.7418","article-title":"HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K\/Akt\/mTOR signaling pathway in human gliomas","volume":"7","author":"Zhu","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.intimp.2026.116444_bb0310","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.apsb.2018.01.008","article-title":"Targeting ERK, an Achilles\u2019 heel of the MAPK pathway, in cancer therapy","volume":"8","author":"Liu","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.intimp.2026.116444_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21031102","article-title":"Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity","volume":"21","author":"Lee","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.intimp.2026.116444_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137353","article-title":"Immunomodulatory properties of PI3K\/AKT\/mTOR and MAPK\/MEK\/ERK inhibition augment response to immune checkpoint blockade in melanoma and triple-negative breast cancer","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2026.116444_bb0325","article-title":"ASN007 is a selective ERK1\/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors","volume":"2","author":"Portelinha","year":"2021","journal-title":"Cell Rep. Med."},{"issue":"10","key":"10.1016\/j.intimp.2026.116444_bb0330","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.7150\/jca.84654","article-title":"Targeting ESM1\/ VEGF\u03b1 signaling axis: a promising therapeutic avenue for angiogenesis in cervical squamous cell carcinoma","volume":"14","author":"Li","year":"2023","journal-title":"J. Cancer"},{"issue":"12","key":"10.1016\/j.intimp.2026.116444_bb0335","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.7150\/ijbs.100276","article-title":"ESM1 facilitates the EGFR\/HER3-triggered epithelial-to-mesenchymal transition and progression of gastric cancer via modulating interplay between Akt and angiopoietin-2 signaling","volume":"20","author":"Yang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"17","key":"10.1016\/j.intimp.2026.116444_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14174124","article-title":"P2Y2R-mediated PAK1 activation is involved in ESM-1 overexpression in RT-R-MDA-MB-231 through FoxO1 regulation","volume":"14","author":"Jin","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.intimp.2026.116444_bb0345","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-20379-7","article-title":"EGFR\/SRC\/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma","volume":"12","author":"Fang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116444_bb0350","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-022-01547-3","article-title":"Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR\/Src\/Erk\/SP1 signaling-mediated ERR\u03b1 re-expression","volume":"21","author":"Pan","year":"2022","journal-title":"Mol. Cancer"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926002882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926002882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:11:51Z","timestamp":1777619511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926002882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":70,"alternative-id":["S1567576926002882"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116444","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CuET inhibits Ewing sarcoma of bone progression through modulation of the ESM1-MAPK\/ERK signaling axis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116444"}}